PBF Energy drops 9% in a week while its biggest shareholder keeps selling

PBF Energy fell 9% over the past week to $83, a move roughly twice as sharp as the median decline of 3.1% across its closest refining peers. VLO lost 5%, PARR dropped 5.3%, and MPC gave back less than half a percent. The underperformance is not just about crack spreads. The stock's biggest registered holder has been selling in size for six consecutive weeks, short interest has crept higher all month, and options traders have swung from hedging to call-buying right as the stock weakened. Earnings land on October 29.

The most concrete pressure on the share price is coming from Control Empresarial de Capitales, the Mexican holding company associated with Carlos Slim. The entity has filed open-market sales totalling around 905,000 shares since early September, none of them under a pre-arranged trading plan, with transaction values across the cluster exceeding $75 million. Its reported stake has fallen from 17.3% to 14.3% across the most recent 13D/G amendments, the latest filed July 30. It remains the single largest declared holder at roughly 13.3 million shares as of October 8, ahead of BlackRock's 12.2 million, but the direction of travel is clear. Under SEC rules, 13D/G positions are event-driven disclosures around the 5% threshold; the stake shown is as last disclosed, and a holder can reduce below 5% without filing again.

Short interest has been quietly building through this same period, rising about 3.7% over the past month to 10.3% of the free float, or roughly 11.9 million shares. That is a meaningfully elevated level for a refiner. Borrowing, however, remains cheap at 0.39% annually, down 22% on the week, and availability is extremely loose at over 4,300% of current short interest. There is no squeeze pressure here. The short book is growing modestly, but the lending market is wide open, suggesting the incremental sellers are not scrambling for stock. The ORTEX short score of 49.3 places PBF in the middle of the universe, consistent with a stock that is shorted but not extreme.

Options positioning has turned notably bullish even as the stock fell. The put/call ratio hit 0.64 on Tuesday, more than two standard deviations below its 20-day average of 0.77, making it one of the lowest defensive readings of the past year. A month ago the PCR was running above 0.86, and it has compressed steadily since. Call-side demand dominating into a 9% weekly decline is an unusual setup. It may reflect traders buying upside into the October 29 print, particularly given that the stock jumped 14% the day after its last quarterly release. That five-day gain reversed to a 3.3% loss, which is the only comparable earnings reaction in the recent history provided.

The Street has been lifting targets without changing its cautious stance. Goldman Sachs raised its target to $91 from $81 on October 9, keeping its Neutral rating. Mizuho went from $65 to $89, also Neutral, on October 8. Citigroup moved to $91 from $74, still Neutral. Morgan Stanley, which carries an Underweight, raised its target to $76. The consensus target of roughly $84 sits within 1% of the current price, meaning the Street is essentially saying the stock is fairly valued right here. Factor scores underline the mixed picture: EPS momentum is in the 94th percentile over 30 days and the 97th over 90 days, and EPS surprise ranks in the 80th percentile. But forward EPS growth ranks only in the 35th percentile, and the short score rank is in the 20th, both muted signals. The EV/EBITDA multiple is running at 3.2x, down sharply over 30 days.

One structural mechanic worth tracking independently: ORTEX puts the probability of PBF graduating from the Russell 2000 to the Russell 1000 at 52% in the December 2026 Semi-Annual Review, with the rank date on October 30. The stock closed at $83 on Tuesday. The price that decides the index rule, as computed by ORTEX, is $83.15 for the Russell 2000 exit and $82.85 for the Russell 1000 entry. The stock is sitting almost exactly on the line. An addition would require an estimated $411 million of buying by index trackers; a deletion would force roughly $1.1 billion of selling across a four-day volume equivalent. The announcement date, if the review goes ahead on schedule, is November 13. Among 351 past Russell 2000 deletions of a similar kind, 80% moved in the expected direction by the effective date, though the median outcome was a 4.3% decline from announcement to effective.

The October 30 rank date and the October 29 earnings print land within 24 hours of each other, making the next eight days the most data-dense period for this stock in months.